US Patent 9902742 Macrocycles as factor XIa inhibitors
Patent 9902742 was granted and assigned to Bristol-Myers Squibb on February, 2018 by the United States Patent and Trademark Office.
All edits
Edits on 7 Aug, 2024
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Patent Citations Received
0
Edits on 25 Jul, 2024
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Patent Citations Received
0
Edits on 7 Dec, 2023
Golden AI
Edits made to:
Article (+72 characters)
Article
Patent abstract
The present invention provides compounds of Formula (Ia):
Edits on 1 Oct, 2023
Golden AI
Edits made to:
Infobox (+8 properties)
Infobox
Patent Inventor Names
Donald J. P. Pinto0
James R. Corte0
Leon M. Smith, II0
Paul J. Gilligan0
Tianan Fang0
William R. Ewing0
Wu Yang0
Yufeng Wang0
Edits on 7 Jun, 2023
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Patent Citations Received
Edits on 18 May, 2023
Golden AI
Edits made to:
Infobox (+1/-1 properties)
US Patent 09902742 Macrocycles as factor XIa inhibitors US Patent 9902742 Macrocycles as factor XIa inhibitors
Infobox
Patent Number
099027420
Patent Number
99027420
Edits on 21 Mar, 2023
Golden AI
Infobox
Is a
Patent Applicant
Current Assignee
Patent Jurisdiction
Patent Number
099027420
Date of Patent
February 27, 2018
0Patent Application Number
154376050
Date Filed
February 21, 2017
0Patent Primary Examiner
Edits on 19 Jan, 2022
Golden AI
Edits made to:
Infobox (+9 properties)
US Patent 09902742 Macrocycles as factor XIa inhibitors
Infobox
Is a
Patent applicant
Current assignee
Patent jurisdiction
Patent number
09902742
Date of patent
February 27, 2018
Patent application number
15437605
Date Filed
February 21, 2017
Patent primary examiner
Find more entities like US Patent 9902742 Macrocycles as factor XIa inhibitors
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
